UBS Group AG - PREDICTIVE ONCOLOGY INC ownership

PREDICTIVE ONCOLOGY INC's ticker is and the CUSIP is 74039M200. A total of 24 filers reported holding PREDICTIVE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PREDICTIVE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$7,822
+1284.4%
23,922
+1213.7%
0.00%
Q4 2022$565
-90.6%
1,821
-88.6%
0.00%
Q3 2022$6,00016,043
+2790.6%
0.00%
Q2 2022$0
-100.0%
555
-98.5%
0.00%
Q4 2021$35,000
+40.0%
36,666
+95.2%
0.00%
Q3 2021$25,000
+400.0%
18,788
+411.2%
0.00%
Q2 2021$5,000
-81.5%
3,675
-90.2%
0.00%
Q4 2020$27,000
+1250.0%
37,386
+1274.0%
0.00%
Q3 2020$2,000
-71.4%
2,721
-34.6%
0.00%
Q2 2020$7,000
-22.2%
4,161
-30.5%
0.00%
Q1 2020$9,000
+80.0%
5,990
+196.4%
0.00%
Q4 2019$5,0002,0210.00%
Other shareholders
PREDICTIVE ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
CARNEGIE MELLON UNIVERSITY 207,144$202,0000.08%
Prosperity Consulting Group, LLC 11,097$11,0000.01%
Fusion Capital, LLC 11,750$11,0000.01%
Virtu Financial LLC 67,145$66,0000.01%
PSI Advisors, LLC 7,963$8,0000.00%
Csenge Advisory Group 22,500$22,0000.00%
NewSquare Capital LLC 5,000$5,0000.00%
Private Advisor Group, LLC 27,805$27,0000.00%
Focused Wealth Management, Inc 200$00.00%
JANE STREET GROUP, LLC 13,816$13,0000.00%
View complete list of PREDICTIVE ONCOLOGY INC shareholders